#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Depression Canavan disease Solitary fibrous tumour Vernal keratoconjunctivitis Neuroblastoma Myxofibrosarcoma Small intestine leiomyosarcoma Follicular lymphoma stage III Glomerulonephritis acute Anaemia Gaucher's disease type III Gastrointestinal disorder Albright's disease Demyelination Anti-myelin-associated glycoprotein antibodies positive More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Treatment Systemic sclerosis pulmonary – Basic Information Congenital generalised lipodystrophy Stevens-Johnson syndrome – Trials in Disease Uterine leiomyosarcoma – Diagnostics Adrenogenital syndrome Acute respiratory distress syndrome – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Glycogen storage disease type II – Treatment Isodicentric chromosome 15 syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BMS-986470 Gskvx000000009151 The-630 Sitravatinib Malate Temsirolimus Ttx-030 Vibostolimab Raludotatug Deruxtecan Amivantamab Indacaterol Acetate Carboplatin Mrna-3210 Olaparib Teriflunomide Immunoglobulin A LIPASE Prasterone Zilucoplan Sodium Clozapine Rbl005.3 More therapies…

    Learn about Your Condition

    Sinus rhythm Small cell lung cancer Pancreatic fistula Spinal cord injury cervical Hodgkin's disease recurrent Tympanic membrane hyperaemia Rhabdoid tumour Breast cancer metastatic Neuropathic arthropathy Dystonia Mantle cell lymphoma recurrent Peritoneal cancer index Epileptic encephalopathy Fragile X syndrome Rectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rheumatoid arthritis

  • Study on the Long-Term Safety and Effectiveness of Filgotinib for Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    Bulgaria Germany Hungary

  • Study on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Anhydrous Caffeine
    • Leflunomide
    • Paracetamol Ph. Eur.
    Germany Hungary Poland

  • Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +5

  • Study on Thiamine for Reducing Fatigue in Rheumatoid Arthritis Patients

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Benfotiamine
    Denmark

  • Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia Czechia Estonia France +11

  • Study of LY3871801 for Adults with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Ly3871801
    Czechia France Germany Hungary Poland Slovakia
Previous Page
1 … 10 11 12

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!